Target EphA2 receptor for cancer therapy

被引：0

作者：

Wang, Si ^{[1
]}

Stebbins, John ^{[1
]}

Noberini, Roberta ^{[1
]}

Zhang, Ziming ^{[1
]}

Pellecchia, Maurizio ^{[1
]}

Pasquale, Elena ^{[1
]}

Kitada, Shinichi ^{[1
]}

Fisher, Paul ^{[1
]}

机构：

[1] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92130 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 245卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

342-MEDI

引用

页数：1

共 50 条

[21] Roles of EphA2 receptor signaling in prostate cancer development and progression [J].

Lingerak, Ryan ;

Petty, Aaron ;

Guo, Hong ;

Lin, Hebei ;

Shi, Xiaojun ;

Kim, Soyeon ;

Wang, Bingcheng .

CANCER RESEARCH, 2024, 84 (06)

[22] Silencing Epha2 Receptor Increases Sensitivity To Chemotherapy In Lung Cancer [J].

Nasreen, N. ;

Lee, H. ;

Kaye, F. ;

Jantz, M. ;

Mohammed, K. A. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189

[23] Negative regulation of EphA2 receptor by Cbl [J].

Wang, YJ ;

Ota, S ;

Kataoka, H ;

Kanamori, M ;

Li, ZY ;

Band, H ;

Tanaka, M ;

Sugimura, H .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (01) :214-220

[24] The Receptor Tyrosine Kinase EphA2 Is a Direct Target Gene of Hypermethylated in Cancer 1 (HIC1) [J].

Foveau, Benedicte ;

Boulay, Gaylor ;

Pinte, Sebastien ;

Van Rechem, Capucine ;

Rood, Brian R. ;

Leprince, Dominique .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (08) :5366-5378

[25] EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease [J].

Vaught, David B. ;

Merkel, Alyssa R. ;

Lynch, Conor C. ;

Edwards, James ;

Tantawy, Mohammed Noor ;

Hilliard, Timothy ;

Wang, Shan ;

Peterson, Todd ;

Johnson, Rachelle W. ;

Sterling, Julie A. ;

Brantley-Sieders, Dana .

JBMR PLUS, 2021, 5 (04)

[26] EphA2 as a new target for breast cancer and its potential clinical application [J].

Zhou, Lingzhi ;

Lu, Xuejing ;

Zhang, Bensi ;

Shi, Yaqi ;

Li, Zhuang .

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2021, 14 (04) :484-492

[27] Molecular predictors of response to EphA2 targeted therapy in uterine cancer [J].

Sood, A. K. ;

Huang, J. ;

Hu, W. ;

Previs, R. A. ;

Dalton, H. J. ;

Hansen, J. M. ;

Sun, Y. ;

Nick, A. M. ;

Broaddus, R. ;

Coleman, R. L. .

GYNECOLOGIC ONCOLOGY, 2015, 137 :59-59

[28] EphA2 receptor represents a new marker and therapeutic target in glioblastoma multiforme (GBM) [J].

Debinski, W ;

Floyd, JF ;

Harbaugh, DI ;

Gibo, DM .

NEURO-ONCOLOGY, 2004, 6 (04) :336-337

[29] Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy [J].

Zhuang, Guanglei ;

Brantley-Sieders, Dana M. ;

Vaught, David ;

Yu, Jian ;

Xie, Lu ;

Wells, Sam ;

Jackson, Dowdy ;

Muraoka-Cook, Rebecca ;

Arteaga, Carlos ;

Chen, Jin .

CANCER RESEARCH, 2010, 70 (01) :299-308

[30] EPHA2, a promising therapeutic target for hepatocellular carcinoma [J].

Wang, Hao ;

Qiu, Wei .

MOLECULAR & CELLULAR ONCOLOGY, 2021, 8 (03)

← 1 2 3 4 5 →